This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2013
Title: Thomas Blättler: Innovator in Dementia Treatment
Introduction
Thomas Blättler is a notable inventor based in Böckten, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of dementia. With a total of 2 patents, his work focuses on innovative approaches to address Alzheimer's disease.
Latest Patents
Blättler's latest patents include a composition comprising virus-like particles (VLP) chemically coupled to a fragment of the Aβ-1-42 peptide. This invention relates to the administration of a construct for treating patients suffering from dementia, specifically Alzheimer's type dementia. The methods outlined in his patents emphasize dosage regimens and forms for effective treatment.
Career Highlights
Throughout his career, Thomas Blättler has been associated with Novartis AG, a leading global healthcare company. His work has been instrumental in advancing therapeutic options for dementia patients. His innovative approaches have garnered attention in the medical community.
Collaborations
Blättler has collaborated with notable colleagues, including Ana Graf and Matthias Staufenbiel. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Thomas Blättler's contributions to dementia treatment through his innovative patents highlight his role as a key inventor in the medical field. His work continues to pave the way for advancements in therapies for Alzheimer's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile